Upon restoring p53 function in cancer cells derived from KRAS-mutant mouse models of PDAC, there is an observed augmentation in the accumulation of α-ketoglutarate, a metabolite crucial as a critical substrate for demethylating chromatin enzymes. Here, TP53 is linked to cancer.